CED recently announced that its 20th annual Biotech/Life Science Conference is taking place February 21_22, 2011, at the Raleigh Convention Center. CED is presenting the conference in partnership with the North Carolina Biotechnology Center and the North Carolina Biosciences Organization (NCBIO). The 2011 Biotech/Life Science Conference features a diverse group of speakers and panel discussions on timely topics such as financing, personalized medicine and regulatory and reimbursement. Confirmed speakers include: Deirdre P. Connelly, President, North America Pharmaceuticals, GlaxoSmithKline; Robert Cascella, President and CEO, Hologic; David P. King, Chairman and CEO, LabCorp; David Mott, General Partner, NEA (former CEO of MedImmune) and Larry Stern, Chairman and CEO, Talecris Biotherapeutics.
Tweet: @CEDNC 2011 Biotech/Life Science Conference slated for Feb 21-22 in Raleigh NC -http://bit.ly/gFUf9y #entrepreneur #CEDNCLifeScienceCon
To register for the CED Biotech/Life Science Conference, visit http://bit.ly/gFUf9y
Speakers:
Deirdre Connelly
David King
David Mott
Lawrence D. Stern
Robert Cascella
No comments:
Post a Comment